A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...
(Howard Dean, 11/13) Miami Herald: CDC Numbers Offer Good News On HIV Infections Overall But Reveal A Crisis For Latinos When the Centers for Disease Control and Prevention published data in May of ...
LAHORE: In what appeared to be a distressing incident, a kidney-failure patient died while 30 others contracted Human ...
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...
HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...
The partnership focuses on improving the national response to Human Immunodeficiency Virus (HIV) and tuberculosis ... the ...
The emergence of new viruses is often unpredictable, jumping as they might from infecting one species to another. A November ...
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...
Gammora is a HIV-1 integrase-derived peptide that works to target the disease by stimulating the insertion of the virus’s ...
Journey to Surviving Cervical Cancer Why women aren't lining up for life-saving screening, vaccine Teachers at the forefront ...